DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study - Wikidata - awgldk - TriplyDB

DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study

DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study

http://www.wikidata.org/entity/Q33418948

about

Chemotherapy Induces Oral Mucositis in Mice Without Additional Noxious Stimuli.

P2860

Q38664413-14638408-7D4A-434E-8EB4-E466CEA192C8

P2860

DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study

http://www.wikidata.org/entity/Q33418948

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

DCF intraperitoneal and intrav ...... ic cancer: A feasibility study

@ast

DCF intraperitoneal and intrav ...... ic cancer: A feasibility study

@en

type

label

DCF intraperitoneal and intrav ...... ic cancer: A feasibility study

@ast

DCF intraperitoneal and intrav ...... ic cancer: A feasibility study

@en

prefLabel

DCF intraperitoneal and intrav ...... ic cancer: A feasibility study

@ast

DCF intraperitoneal and intrav ...... ic cancer: A feasibility study

@en

P1433

Q33418948-C827F86B-4F81-4480-B6B9-EB2682C10A40

P1476

Q33418948-702FDECD-9158-46BC-B8AE-6D00258A01AF

P2093

Q33418948-13159D6D-CCF9-415A-A118-1C3E3405757A

Q33418948-14F59EDF-5D2E-4365-8BE5-499742FA3C5E

Q33418948-1714E831-DC08-4DC6-BCC4-1EFEDE852A2C

Q33418948-384E494E-636F-4476-A80D-D2CFE735E9DF

Q33418948-4F65E933-40A0-46B7-BC1B-9613FB51C7B5

Q33418948-8A0B53EF-33DE-4AAB-B88A-5D899C023800

Q33418948-A599765C-73E6-4D70-8B2A-51C4B8F62789

Q33418948-A85503F8-AEE6-4BC4-9020-A18790EBCEC8

Q33418948-C882F6FF-5ADC-4693-BC12-A4D5C1F8EA57

Q33418948-D60D17F3-E02C-495D-B1E1-86BDB2E656CF

P2860

Q33418948-109488AD-799E-455C-8BC7-F688399D261C

Q33418948-168A8F03-BE8F-49E4-8559-6F4BB6B71288

Q33418948-1F0EF9C4-7AD9-4891-B404-59465C530A09

Q33418948-25FD5261-4245-4255-BBB6-945EF840FA44

Q33418948-2D315460-54FB-4D79-9699-3838AC2ADAAC

Q33418948-631E48A2-45E1-4EA3-B519-EA6A2E579855

Q33418948-664D1B20-AD77-45C4-922A-5F4C0AEB54EC

Q33418948-78CE5E4B-D283-4084-AEFA-3B905641E571

Q33418948-7A010321-6435-4B47-A4BC-9B2A5315DD18

Q33418948-9A114C7B-BA64-4115-988C-336C96038EAF

P304

Q33418948-3626F856-FB68-4511-BE88-728432634036

P31

Q33418948-81CFF30D-BB22-4B36-A96E-0AF764D0363E

P356

Q33418948-F9F31DB4-BB55-46FD-9104-05C11AAD6058

P433

Q33418948-BE9310BE-AB3B-4295-B610-46F4F2E69E30

P478

Q33418948-B14DB53E-20FE-476A-9227-B72B2BA736ED

P577

Q33418948-0754984E-7590-4B2A-96B4-4C7DEDEF55D5

P5875

Q33418948-EB01B8B7-D3DC-48A4-9E37-7BCC2B52DB0F

P698

Q33418948-3E43C13C-B99C-4BD5-A238-8A444055AFE2

P932

Q33418948-091B305B-CE96-4C8A-844C-94D249B10138

P356

P1433

Oncology Letters

P1476

DCF intraperitoneal and intrav ...... ic cancer: A feasibility study

@en

P2093

Feng-Jie Meng

http://www.w3.org/2001/XMLSchema#string

Hai-Gang Wang

http://www.w3.org/2001/XMLSchema#string

Liu-Bin Chen

http://www.w3.org/2001/XMLSchema#string

Qiang Lin

http://www.w3.org/2001/XMLSchema#string

Shun-Mao Ma

http://www.w3.org/2001/XMLSchema#string

Xiao-Can Ren

http://www.w3.org/2001/XMLSchema#string

Xue-Ji Chen

http://www.w3.org/2001/XMLSchema#string

Yu Peng

http://www.w3.org/2001/XMLSchema#string

Yue-E Liu

http://www.w3.org/2001/XMLSchema#string

Zeng-Li Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Systematic review of intraperitoneal chemotherapy for gastric cancer.

Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis.

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials.

Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.

P304

491-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2014.2651

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268985562

http://www.w3.org/2001/XMLSchema#string

P698

25436015

http://www.w3.org/2001/XMLSchema#string

P932

4246631

http://www.w3.org/2001/XMLSchema#string